'Statistical analysis plan' diaporamas de présentation

SECONDARY ANALYSES IN CLINICAL TRIALS

SECONDARY ANALYSES IN CLINICAL TRIALS. Presented by: George Bigelow, PhD Daniel J. Feaster, PhD Abigail G. Matthews , PhD December 6, 2013. Objectives. Review the statistical issues with analyzing and interpreting secondary analyses, and demonstrate the multiple testing burden

991 views • 80 slides

Statistical Analysis Plan and Clinical Study Report

2.15k views • 44 slides

What is the Format & Content for a Premarket Approval (PMA) Submission?

What is the Format & Content for a Premarket Approval (PMA) Submission?. Carole C. Carey BSEE, MEng carole.carey@fda.hhs.gov Director, International Staff US Food and Drug Administration (USFDA) Center for Devices and Radiological Health (CDRH). Learning Objectives.

1.45k views • 43 slides

Managing missing data

Session 4: Analysis and reporting Managing missing data Rob Coe (CEM, Durham) Developing a statistical analysis plan Hannah Buckley (York Trials Unit) Panel on EEF reporting and data archiving Jonathan Sharples, Camilla Nevill, Steve Higgins and Andrew Bibby. Managing missing data . Rob Coe

521 views • 37 slides

679 views • 36 slides

REDCap Treatment Randomization Module

997 views • 23 slides

129 views • 12 slides

113 views • 11 slides

Thibela ~ outstanding issues

Thibela ~ outstanding issues. Mixing between clusters Sampling strategy for final TB culture prevalence survey Availability of ART Statistical analysis plan ~ issues Database solution HIV prevalence. Mixing between/outside clusters. Measure of contamination across clusters

165 views • 8 slides

HL7 Working Group Meeting 12 September 2006

194 views • 7 slides